Brainstorm Cell Valuation
| GHDN Stock | EUR 2.69 0.00 0.00% |
Based on Macroaxis valuation methodology, the firm appears to be overvalued. Brainstorm Cell Ther shows a prevailing Real Value of €2.47 per share. The current price of the firm is €2.69. Our model approximates the value of Brainstorm Cell Ther from analyzing the firm fundamentals such as return on equity of -1.93, and Current Valuation of 44.56 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Brainstorm Cell's price fluctuation is risky at this time. Calculation of the real value of Brainstorm Cell Ther is based on 3 months time horizon. Increasing Brainstorm Cell's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Brainstorm stock is determined by what a typical buyer is willing to pay for full or partial control of Brainstorm Cell Therapeutics. Since Brainstorm Cell is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Brainstorm Stock. However, Brainstorm Cell's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.69 | Real 2.47 | Hype 2.69 | Naive 2.82 |
The real value of Brainstorm Stock, also known as its intrinsic value, is the underlying worth of Brainstorm Cell Ther Company, which is reflected in its stock price. It is based on Brainstorm Cell's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Brainstorm Cell's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Brainstorm Cell Therapeutics helps investors to forecast how Brainstorm stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Brainstorm Cell more accurately as focusing exclusively on Brainstorm Cell's fundamentals will not take into account other important factors: Brainstorm Cell Total Value Analysis
Brainstorm Cell Therapeutics is currently forecasted to have takeover price of 44.56 M with market capitalization of 74.73 M, debt of 3.04 M, and cash on hands of 6.22 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Brainstorm Cell fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
44.56 M | 74.73 M | 3.04 M | 6.22 M |
Brainstorm Cell Asset Utilization
One of the ways to look at asset utilization of Brainstorm is to check how much profit was generated for every dollar of assets it reports. Brainstorm Cell Therapeutics shows a negative utilization of assets of -0.68 percent, losing €0.006831 for each euro of assets held by the firm. Unsuccessful asset utilization signifies that the company is being less effective with each euro of assets it shows. Put another way, asset utilization of Brainstorm Cell Therapeutics shows how unproductive it operates for each euro spent on its assets.Brainstorm Cell Ownership Allocation
Brainstorm Cell holds a total of 36.54 Million outstanding shares. Brainstorm Cell Therapeutics retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Brainstorm Cell Profitability Analysis
Net Loss for the year was (24.46 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Brainstorm Cell's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Brainstorm Cell and how it compares across the competition.
About Brainstorm Cell Valuation
The stock valuation mechanism determines Brainstorm Cell's current worth on a weekly basis. Our valuation model uses a comparative analysis of Brainstorm Cell. We calculate exposure to Brainstorm Cell's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Brainstorm Cell's related companies.Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of central nervous system adult stem cell therapies designed to address the unmet medical needs of patients with debilitating neurodegenerative diseases. Brainstorm Cell Therapeutics Inc. was founded in 2000 and is headquartered in New York, New York. BRAINSTORM operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 31 people.
8 Steps to conduct Brainstorm Cell's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Brainstorm Cell's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Brainstorm Cell's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Brainstorm Cell's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Brainstorm Cell's revenue streams: Identify Brainstorm Cell's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Brainstorm Cell's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Brainstorm Cell's growth potential: Evaluate Brainstorm Cell's management, business model, and growth potential.
- Determine Brainstorm Cell's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Brainstorm Cell's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Brainstorm Stock analysis
When running Brainstorm Cell's price analysis, check to measure Brainstorm Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainstorm Cell is operating at the current time. Most of Brainstorm Cell's value examination focuses on studying past and present price action to predict the probability of Brainstorm Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainstorm Cell's price. Additionally, you may evaluate how the addition of Brainstorm Cell to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |